New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents

por Metjian, Ara, Abrams, Charles S
Publicado 2009

Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura

por Hanlon, Ashley, Metjian, Ara
Publicado 2020

Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature

por Nipp, Ryan, Mitchell, Aaron, Pishko, Allyson, Metjian, Ara
Publicado 2014

C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy

por Shah, Hridaya, Chen, Hang, Pan, Xiang-Zuo, Metjian, Ara, Brodsky, Robert A., Braunstein, Evan M., Chaturvedi, Shruti
Publicado 2022

Safety and tolerability of solvent/detergent‐treated plasma for pediatric patients requiring therapeutic plasma exchange: An open‐label, multicenter, postmarketing study

por Josephson, Cassandra D., Goldstein, Stuart, Askenazi, David, Cohn, Claudia S., Spinella, Philip C., Metjian, Ara, Fasano, Ross M., Music‐Aplenc, Lejla
Publicado 2021

Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study

por Knoebl, Paul, Cataland, Spero, Peyvandi, Flora, Coppo, Paul, Scully, Marie, Kremer Hovinga, Johanna A., Metjian, Ara, de la Rubia, Javier, Pavenski, Katerina, Minkue Mi Edou, Jessica, De Winter, Hilde, Callewaert, Filip
Publicado 2019

Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study

por Scully, Marie, de la Rubia, Javier, Pavenski, Katerina, Metjian, Ara, Knöbl, Paul, Peyvandi, Flora, Cataland, Spero, Coppo, Paul, Kremer Hovinga, Johanna A., Minkue Mi Edou, Jessica, De Passos Sousa, Rui, Callewaert, Filip, Gunawardena, Sriya, Lin, Julie
Publicado 2022